Cited by 62Thyroid Disorders and TreatmentsThyroid and Parathyroid SurgeryThyroid Cancer Diagnosis and Treatment

Monitoring Therapy in Patients Taking Levothyroxine

Helfand, Mark, Crapo, Lawrence M.·1990·Annals of Internal Medicine

Abstract

PURPOSE: To evaluate the use of thyroid function tests to monitor therapy in patients taking levothyroxine. DATA IDENTIFICATION: Studies published between 1966 and January 1990 were identified through computer searches and references of identified studies. STUDY SELECTION: Studies that included a careful description of the patients under study, well-defined interventions, and a meaningful criterion standard were emphasized. DATA EXTRACTION: Data from different studies were combined to estimate the probability of positive and negative test results in well-defined clinical situations. Informal methods of synthesizing evidence were used when combining data from different studies was not justified. RESULTS: The sensitive thyrotropin (TSH) test is the preferred method to monitor therapy because it agrees with physiologic measures of thyroid hormone effect. Among clinically euthyroid patients who take 100 to 150 micrograms/d of levothyroxine, the probability that the sensitive thyrotropin will be undetectable is close to 50%. These patients are most likely to benefit from testing. Patients who take over 250 micrograms/d are almost certain to have undetectable sensitive thyrotropin levels; in these patients, the dose may be lowered without testing. CONCLUSIONS: Adequate long-term studies are needed to determine the role of biochemical testing in monitoring therapy. Current evidence suggests that the sensitive thyrotropin test should be used to monitor therapy. Clinically euthyroid patients taking lower dosages of levothyroxine are most likely to benefit from testing.

Integrity signals

Registry

Crossref · 10.7326/0003-4819-113-6-450

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Helfand, M., & Crapo, L. M.
Affiliations
Stanford Medicine (US)
Corresponding author
Helfand, Mark
Venue
Annals of Internal Medicine
Published
1990-09-15
Volume
113
Issue
6
Pages
450-454
ISSN
  • 0003-4819 (ISSN-L)
  • 1539-3704
OpenAlex
W2017179329
Cited by
62
References
4
Citations by year
2026: 1 · 2025: 1 · 2021: 1 · 2020: 2 · 2019: 1 · 2018: 1 · 2017: 1 · 2016: 1 · 2014: 1 · 2013: 1 · 2012: 3
FWCI
1.16
Type
journal article
Language
en
Open access
closed
Locations
  • Annals of Internal Medicine (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
  • Health Sciences › Medicine › Surgery › Thyroid and Parathyroid Surgery
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Cancer Diagnosis and Treatment
Keywords
levothyroxine, thyroid function tests, thyroid hormone replacement, treatment monitoring, euthyroid patients, dose adjustment, test sensitivity
MeSH terms
Humans, Hypothyroidism, Predictive Value of Tests, Thyroid Function Tests, Thyroid Neoplasms, Thyrotropin, Thyroxine, Meta-Analysis as Topic

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review